PrimaryCareNOW: A Virtual CME Conference
 
Thank you to all who joined us live for our June 26 virtual conference. If you were not able to join us live, most sessions have been recorded and are available below.

Agenda

  CME/CE Accredited Session

Non CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

8–9am ET

Gastroenterology

9:10–10:10am ET

Endocrinology 

 

Adults with type 2 diabetes mellitus (T2DM) have a two- to four-fold increase in risk for cardiovascular (CV) morbidity and mortality. This session cuts to the heart of primary and secondary prevention in this population, presenting recent data on antihyperglycemic medications with proven cardiovascular benefit in the context of updated management algorithms. Individualized treatment is critical to the success of these treatment plans. The faculty will help you optimize adherence through shared decision-making tactics that account for CV risk factors, comorbidities, and patient preferences.

Archana R. Sadhu, MD, FACE 

Archana R. Sadhu, MD, FACE

Director, System Diabetes Program; Houston Methodist Hospital, Director, Transplant Endocrinology Houston Methodist Hospital, Houston, TX; Assistant Professor of Medicine, Weill Cornell Medical College, New York, NY; Adjunct Assistant Professor, Texas A!M Health Science Center, Dallas Campus, Dallas, TX 

Charles Vega, MD, FAAFP 

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine; Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine Irvine, CA 

Supported by Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com

10:20–11:20am ET

Neurology

A Head Start on Migraine: Emerging Approaches to Acute Management 

Jessica Ailani, MD, FAHS, FAAN | M. Susan Burke, MD, FACP | Rashmi B. Halker Singh, MD, FAHS, FAAN

 

With the latest on new and emerging approaches treatment and the most up-to-date patient-centered strategies, this talk will give you a head start on managing acute migraine. Faculty will illustrate the features of acute migraine to help you distinguish it from other headache types and use interactive patient cases to impart practice-changing takeaways about patient management.

Jessica Ailani, MD, FAHS, FAAN 

Jessica Ailani, MD, FAHS, FAAN

Director, Medstar Georgetown Headache Center; Professor of Clinical Neurology, Medstar Georgetown University Hospital, Georgetown, MD

M. Susan Burke, MD, FACP 

M. Susan Burke, MD, FACP

Clinical Associate Professor of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Senior Advisor, Lankenau Medical Associates, Lankenau Medical Center, Wynnewood, PA

Rashmi B. Halker Singh, MD, FAHS, FAAN 

Rashmi B. Halker Singh, MD, FAHS, FAAN

Headache Fellowship Program Director, Assistant Professor of Neurology, Mayo Clinic, Scottsdale, AZ

Supported by Allergan

11:25am–12:10pm ET

Industry Theater

 

This program will highlight a different approach to the treatment of heart failure with reduced ejection fraction (HFrEF). By targeting a mechanism of action aligned to pathophysiologic pathways, it is possible to reduce patient mortality and morbidity, while providing a proven safety and tolerability profile to help provide confidence in selecting your first-choice therapy for patients with HFrEF.

Javed Butler, MD, MPH, MBA 

Javed Butler, MD, MPH, MBA

Chairman and Professor, Department of Medicine, University of Mississippi, Jackson, MS

Sponsored by Novartis

12:15–1:15pm ET

Cardiology

Clinical Considerations on Lipid Management of ASCVD in the New Era  

Harold E. Bays, MD, FOMA, FTOS, FACC, FACE, FNLA, FASPC | Eliot A. Brinton, MD, FAHA, FNLA, FACE


 

Providing practical information in an informative format focused on lipid management of ASCVD in the New Era, learners will be provided with important changes in ASCVD guidelines, recognition of elevated triglyceride levels as a target for therapy, a review of clinical trials that recently made a difference in lipid management, practical considerations on using lipid-modifying therapies, and the latest on omega-3 fatty acids for ASCVD.

Harold E. Bays, MD, FOMA, FTOS, FACC, FACE, FNLA, FASPC 

Harold E. Bays, MD, FOMA, FTOS, FACC, FACE, FNLA, FASPC

Medical Director/President, Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY

Eliot A. Brinton, MD, FAHA, FNLA, FACE 

Eliot A. Brinton, MD, FAHA, FNLA, FACE

Past President, American Board of Clinical Lipidology; President, Utah Lipid Center

Supported by Amarin Pharma Inc.

1:20–2:20pm ET

Pulmonology

Severe Asthma in Primary Care: New Strategies for Management 

Christopher H. Fanta, MD | Gerald W. Smetana, MD

 

 

The most recent CDC report estimates an asthma prevalence of 7.9% in the U.S. Although patients with severe asthma make up only 3–10% of the total asthma population, they account for a substantial proportion of asthma morbidity and health expenditures. With the emergence of new biologic therapies targeting cytokines involved in pathogenesis of asthma, severe asthma is no longer considered the “refractory” disease of yesteryear. This session offers guidance on distinguishing characteristics pertinent to individualizing asthma treatment, such as subtype, phenotype, and endotype as well as biomarkers and other measures of assessment that identify patients with severe eosinophilic asthma. Using expert guidelines, the faculty will discuss how to apply these individual factors to treatment management and alleviate the burden of asthma in your practice.

Christopher H. Fanta, MD 

Christopher H. Fanta, MD

Professor of Medicine, Harvard Medical School, Boston, MA; Director, Partners Asthma Center, Member, Pulmonary and Critical Care Division, Brigham and Women's Hospital, Boston, MA

Gerald W. Smetana, MD 

Gerald W. Smetana, MD

Professor of Medicine, Harvard Medical School, Boston, MA; Clinician Educator, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA

Supported by GlaxoSmithKline

2:30–3:30pm ET

Infectious Disease

Managing Influenza: Practical Strategies For Primary Care

Paul E. Sax, MD | Daniel A. Solomon, MD


 

Is influenza going viral in your practice? This session on influenza diagnosis and management will improve how you respond when annual fluctuations in vaccine efficacy expose your patients to risk of serious illness. Through interactive patient cases, the faculty will demonstrate how to identify and treat patients with suspected influenza, including patients at high risk for complications. These practical, evidence-based strategies will help you to use antiviral medications effectively and reduce the burden of influenza.

Paul E. Sax, MD 

Paul E. Sax, MD

Clinical Director, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA; Professor of Medicine, Harvard Medical School, Boston, MA

Daniel Solomon, MD 

Daniel Solomon, MD

Associate Physician, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School

Supported by Genentech

3:40–4:10pm ET

Infectious Disease

COVID-19 Panel Discussion 

Pamela Kushner, MD, FAAFP | Paul E. Sax, MD | Daniel A. Solomon, MD

 

These troubling times require communication among specialists and primary care. In this COVID-19 panel, primary care and infectious disease faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.

Pamela Kushner, MD, FAAFP 

Pamela Kushner, MD, FAAFP

Clinical Professor, University of California Irvine Medical Center; Director, Kushner Wellness Center, Los Alamitos, CA

Paul E. Sax, MD 

Paul E. Sax, MD

Clinical Director, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA; Professor of Medicine, Harvard Medical School, Boston, MA

Daniel Solomon, MD 

Daniel Solomon, MD

Associate Physician, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School

4:15–4:50pm ET

Industry Theater

 

We will examine the risk of heart failure (HF) among patients with type 2 diabetes (T2D) and explore evidence-based risk reduction strategies that you can incorporate into your practice.

Dr. Michael Cobble 

Dr. Michael Cobble

Director and Clinician, Canyons Medical Center Sandy, UT

Sponsored by AstraZeneca

4:15–5:00pm ET

Industry Theater

 

 

In this session, we will discuss the clinical impact and physiology of overactive bladder as well as the latest perspectives on management and treatment.

David Staskin, MD 

David Staskin, MD

Attending in Urology, St. Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, MA

Sponsored by Astellas Pharma US, Inc.

5:10–6:10pm ET

Hot Topic

First Steps in Diversity, Cultural Humility, and Patient Care 

Gregory L. Hall, MD | Charles Vega, MD, FAAFP

 

This session will shine a light on health disparities in the U.S. and discuss ways to overcome them by embracing diversity, combatting bias, and employing cultural competency to improve patient-provider communication. These valuable tips can ultimately enhance healthcare for your patients of all races, ethnicities, and cultures.

Gregory L. Hall, MD 

Gregory L. Hall, MD

Associate Professor of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH; Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH; Assistant Clinical Professor in Medicine, Case Western Reserve University School of Medicine, Cleveland, OH; Director, Center for African American Health, Research, Education & Policy, Cleveland, OH

Charles Vega, MD, FAAFP 

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine; Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine Irvine, CA